Results 231 to 240 of about 1,149,461 (264)
Some of the next articles are maybe not open access.

The Cellular Basis of Tumor Progression

1997
Variability in disease presentation and course is a hallmark of cancer. Variability is seen among similarly diagnosed cancers in different patients or animal hosts and in the same cancer at different periods of time. This latter type of variability, termed "tumor progression," was defined by Foulds in a series of six rules that describe the independent
G H, Heppner, F R, Miller
openaire   +2 more sources

Tumor Progression and Catastrophe Theory

1993
Progression is the development from bad to worse that is often observed in tumors. It can follow different courses, not only in different organs, but also in the same organ: sometimes there is a smooth, continuous progression from normal to malignant cells, sometimes suddenly a highly malignant tumor arises.
Daams, H.   +3 more
openaire   +2 more sources

HDAC6: Tumor Progression and Beyond

Current Cancer Drug Targets
Histone Deacetylase 6 (HDAC6) is an intriguing therapeutic target in cancer research, distinguished as the only HDAC family member predominantly located in the cytoplasm. HDAC6 features two catalytic domains and a unique ubiquitin-binding domain, which sets it apart from other HDACs.
Joao Marcos Oliveira-Silva   +6 more
openaire   +2 more sources

Tissue architecture in tumor initiation and progression

Trends in Cancer, 2022
Jacco Van Rheenen   +2 more
exaly  

Tumor Progression

2012
Mario Muto, Alessandra D’Amico
  +4 more sources

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages

Frontiers in Oncology, 2022
Lei Zhao, Yang Yong-Guang
exaly  

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression

Frontiers in Immunology, 2021
Tao Xi, Xi Tao, Lufeng Zheng
exaly  

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

International Journal of Molecular Sciences, 2020
Sara Bravaccini   +2 more
exaly  

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

Journal of Experimental Medicine, 2020
Gabriel A Rabinovich   +2 more
exaly  

Control of Tumor Progression by Angiocrine Factors

Cancers, 2021
Andreas Fischer   +1 more
exaly  

Home - About - Disclaimer - Privacy